title: 17β-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1.
abstract: Abstract Traumatic brain injury (TBI) is a significant public health problem in the United States. Despite preclinical success of various drugs, to date all clinical trials investigating potential therapeutics have failed. Recently, sex steroid hormones have sparked interest as possible neuroprotective agents after traumatic injury. One of these is 17β-estradiol (E2), the most abundant and potent endogenous vertebrate estrogen. The goal of our study was to investigate the acute potential protective effects of E2 or the specific G protein-coupled estrogen receptor 1 (GPER) agonist G-1 when administered in an intravenous bolus dose 1 hour post-injury in the lateral fluid percussion (LFP) rodent model of TBI. The results of this study show that, when assessed at 24 hours post-injury, E2 or G-1 confers protection in adult male rats subjected to LFP brain injury. Specifically, we found that an acute bolus dose of E2 or G-1 administered intravenously 1 hour post-TBI significantly increases neuronal survival in the ipsilateral CA 2/3 region of the hippocampus and decreases neuronal degeneration and apoptotic cell death in both the ipsilateral cortex and CA 2/3 region of the hippocampus. We also report a significant reduction in astrogliosis in the ipsilateral cortex, hilus, and CA 2/3 region of the hippocampus. Finally, these effects were observed to be chiefly dose-dependent for E2, with the 5 mg/kg dose generating a more robust level of protection. Our findings further elucidate estrogenic compounds as a clinically relevant pharmacotherapeutic strategy for treatment of secondary injury following TBI, and intriguingly, reveal a novel potential therapeutic target in GPER.
authors: Department of Physical Medicine and Rehabilitation, University of Alabama at Birmingham, Spain Rehabilitation Center, Birmingham, Alabama 35294, USA.
authors: Nicole L
authors: NL
authors: Day
authors: Candace L
authors: CL
authors: Floyd
authors: Tracy L
authors: TL
authors: D'Alessandro
authors: William J
authors: WJ
authors: Hubbard
authors: Irshad H
authors: IH
authors: Chaudry
mesh_terms: D000818:Animals; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control*; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000378:metabolism*
chemical_list: C520305:Gper1 protein, rat; D018696:Neuroprotective Agents; D043562:Receptors, G-Protein-Coupled; D004958:Estradiol
references: Shock. 2008 Nov;30(5):585-9
references: 18391854
references: J Neurotrauma. 2013 Jan 1;30(1):47-54
references: 21851230
references: J Neurotrauma. 2008 Sep;25(9):1121-31
references: 18785877
references: J Comp Neurol. 2012 Aug 15;520(12):2630-46
references: 22684936
references: J Neurotrauma. 2006 Dec;23(12):1814-27
references: 17184191
references: Psychoneuroendocrinology. 2011 Feb;36(2):182-92
references: 20696528
references: J Neurotrauma. 2000 May;17(5):367-88
references: 10833057
references: J Neurotrauma. 2009 Dec;26(12):2185-93
references: 19604100
references: Neuroscience. 2009 Feb 18;158(4):1599-607
references: 19095043
references: Brain Res. 1993 Nov 19;628(1-2):271-8
references: 8313156
references: Neuroscience. 1989;28(1):233-44
references: 2761692
references: Int J Dev Neurosci. 1999 Apr;17(2):145-51
references: 10221674
references: EMBO Rep. 2001 Sep;2(9):775-81
references: 11559590
references: Clin Exp Pharmacol Physiol. 2011 Sep;38(9):577-85
references: 21645039
references: Arch Phys Med Rehabil. 2003 Mar;84(3):343-9
references: 12638101
references: Shock. 2009 Mar;31(3):227-37
references: 18665049
references: J Neurotrauma. 1994 Dec;11(6):657-67
references: 7723065
references: Dialogues Clin Neurosci. 2011;13(3):287-300
references: 22033563
references: J Mol Cell Cardiol. 2006 Sep;41(3):511-21
references: 16859701
references: J Neurosci. 2012 Apr 4;32(14):4887-900
references: 22492045
references: Mol Endocrinol. 2005 Apr;19(4):833-42
references: 15695368
references: J Leukoc Biol. 2008 Mar;83(3):518-22
references: 17938275
references: Am J Pathol. 2007 Apr;170(4):1210-8
references: 17392161
references: J Neurosci Res. 2000 May 1;60(3):321-7
references: 10797534
references: Arch Phys Med Rehabil. 2008 Dec;89(12 Suppl):S69-76
references: 19081444
references: J Neurotrauma. 2010 Mar;27(3):611-26
references: 20001688
references: J Cell Mol Med. 2010 Oct;14(10):2381-92
references: 20738443
references: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8867-72
references: 10430862
references: Crit Care Med. 2007 Sep;35(9 Suppl):S621-9
references: 17713419
references: Pak J Pharm Sci. 2012 Jan;25(1):219-25
references: 22186333
references: J Neurosurg. 1987 Jul;67(1):110-9
references: 3598659
references: Psychosomatics. 2000 Mar-Apr;41(2):95-103
references: 10749946
references: J Biol Chem. 2012 Aug 3;287(32):26817-28
references: 22645130
references: Ann Surg. 2007 Jun;245(6):971-7
references: 17522524
references: J Endocrinol. 2009 Aug;202(2):223-36
references: 19420011
references: J Neurotrauma. 2001 Sep;18(9):891-900
references: 11565601
references: Eur J Neurosci. 2007 May;25(10):3039-46
references: 17561817
references: Brain Res. 2005 Nov 16;1062(1-2):171-4
references: 16256079
references: Clin Exp Pharmacol Physiol. 2007 Aug;34(8):801-8
references: 17600562
references: Brain Inj. 2006 Jan;20(1):23-32
references: 16403697
references: Biochim Biophys Acta. 2010 Oct;1800(10):1113-20
references: 19931595
references: Nat Rev Endocrinol. 2011 Aug 16;7(12):715-26
references: 21844907
references: Horm Behav. 2009 Sep;56(3):309-14
references: 19560466
references: Trends Pharmacol Sci. 2010 Dec;31(12):596-604
references: 21035878
references: Cent Nerv Syst Trauma. 1987;4(2):119-34
references: 3690695
references: J Endocrinol. 2007 May;193(2):311-21
references: 17470522
references: Synapse. 2006 Oct;60(5):406-10
references: 16856173
references: Mol Cell Neurosci. 2011 Nov;48(3):185-94
references: 21803156
references: J Neurotrauma. 2006 Jun;23(6):830-52
references: 16774470
references: MMWR Surveill Summ. 2011 May 6;60(5):1-32
references: 21544045
references: PLoS One. 2010 Jan 08;5(1):e8642
references: 20062809
references: Psychiatr Clin North Am. 2002 Mar;25(1):43-69
references: 11912944
references: Cereb Cortex. 2011 Sep;21(9):2046-55
references: 21258044
references: J Neurotrauma. 2005 Mar;22(3):345-52
references: 15785230
references: Crit Care Med. 2009 Dec;37(12):3097-106
references: 19789448
references: Neuroscience. 2010 Sep 29;170(1):54-66
references: 20619320
references: Neurochem Int. 2011 Jan;58(1):126-33
references: 21093516
references: Brain Pathol. 2004 Apr;14(2):215-22
references: 15193035
references: Endocr Rev. 2007 Dec;28(7):726-41
references: 17916740
references: Neurobiol Aging. 2013 Mar;34(3):887-901
references: 22749492
references: Can J Physiol Pharmacol. 2010 Apr;88(4):414-21
references: 20555409
references: J Neurotrauma. 2002 Mar;19(3):303-16
references: 11939498
references: J Neurotrauma. 2006 Oct;23(10):1450-67
references: 17020482
references: J Neurotrauma. 2005 Jan;22(1):42-75
references: 15665602
references: Br J Anaesth. 2007 Jul;99(1):4-9
references: 17573392
references: Brain Res. 2000 Aug 25;874(2):123-30
references: 10960596
references: Cephalalgia. 2009 Jul;29(7):729-41
references: 19220308
references: Brain Pathol. 1994 Jul;4(3):229-37
references: 7952264
references: J Rehabil Res Dev. 2007;44(7):975-82
references: 18075954